The fact neurabin is primarily in the brain means that altering its activity should not have the potential body-wide impact of directly altering A1 receptor activity, Wang says
Tumor environments rely on similar pathways for progression (vascular growth, cell proliferation)
doi:10.3389/fpsyg.2020.02027
A small number of cancers (basal cell carcinoma, breast cancer, malignant melanoma, lipoma, squamous cell carcinoma) were reported during the 12-week oral METAOD005 trial
Administration frequency varies based on deficiency severity and individual response
Baseline metabolic testing and hormone panels set a baseline, which should be regularly monitored, including glucose metrics, reproductive hormones, and ultrasound as appropriate